Company Information & Drug Savings for BioMarin Pharmaceutical Inc. Medications

BioMarin Pharmaceutical is a global biotechnology company developing therapies for rare genetic diseases. Based in San Rafael, California, BioMarin creates treatments for phenylketonuria (PKU), mucopolysaccharidosis (MPS), Batten disease, and achondroplasia. Key products include Vimizim, Naglazyme, and Aldurazyme for MPS disorders, Palynziq for PKU, and Voxzogo for achondroplasia (dwarfism). BioMarin’s enzyme replacement and gene therapies transform lives of patients with rare inherited conditions.

BioMarin Pharmaceutical Inc.

How to Contact Biomarin Pharmaceutical Inc.

Browse Medications Manufactured by BioMarin Pharmaceutical Inc.

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch